Insider · CIK 0001312622

Foster-Cheek Kaye I

CIK 0001312622 Name as filed on the most recent filing

Filed as Foster-Cheek Kaye I (17)

25 transaction lines · from 17 filings · filed 2009-12-11 to 2024-03-11 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

25 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-03-07 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 40,632, disposed Open Form 4 filing 0001439222-24-000061
2024-03-06 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 141,236, disposed Open Form 4 filing 0001439222-24-000058
2024-03-05 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 9,663, disposed Open Form 4 filing 0001439222-24-000058
2023-08-09 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 648,888, disposed Open Form 4 filing 0001439222-23-000125
2018-06-14 S, Open-market sale Agios Pharmaceuticals IncAGIO 3 lines 841,926, disposed Open Form 4 filing 0001209191-18-038277
2018-03-19 S, Open-market sale Agios Pharmaceuticals IncAGIO 557,396, disposed Open Form 4 filing 0001209191-18-021060
2013-08-06 S, Open-market sale Onyx Pharmaceuticals IncONXX 2 lines 1,179,092, disposed Open Form 4 filing 0001179110-13-012864
2013-05-07 S, Open-market sale Onyx Pharmaceuticals IncONXX 2 lines 797,496, disposed Open Form 4 filing 0001179110-13-008033
2013-04-02 S, Open-market sale Onyx Pharmaceuticals IncONXX 158,359, disposed Open Form 4 filing 0001179110-13-006441
2013-04-01 S, Open-market sale Onyx Pharmaceuticals IncONXX 177,986, disposed Open Form 4 filing 0001179110-13-006441
2013-02-15 S, Open-market sale Onyx Pharmaceuticals IncONXX 1,211,653, disposed Open Form 4 filing 0001179110-13-003191
2012-11-06 S, Open-market sale Onyx Pharmaceuticals IncONXX 539,801, disposed Open Form 4 filing 0001179110-12-015846
2012-10-02 S, Open-market sale Onyx Pharmaceuticals IncONXX 171,436, disposed Open Form 4 filing 0001179110-12-014922
2012-08-06 S, Open-market sale Onyx Pharmaceuticals IncONXX 3 lines 2,080,417, disposed Open Form 4 filing 0001209191-12-041041
2012-07-25 S, Open-market sale Onyx Pharmaceuticals IncONXX 172,724, disposed Open Form 4 filing 0001209191-12-039431
2011-12-05 S, Open-market sale Onyx Pharmaceuticals IncONXX 1,284,902, disposed Open Form 4 filing 0001209191-11-060164
2011-10-03 S, Open-market sale Onyx Pharmaceuticals IncONXX 47,750, disposed Open Form 4 filing 0001209191-11-050303
2011-09-23 S, Open-market sale Onyx Pharmaceuticals IncONXX 53,435, disposed Open Form 4 filing 0001209191-11-049082
2009-12-10 S, Open-market sale Johnson & JohnsonJNJ 6,265,012, disposed Open Form 4 filing 0000200406-09-000142

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 25
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Foster-Cheek Kaye I, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001312622

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.